Clin2
NCT07309562Possibly a fitRecruiting

Growth hormone trial for short children born small

Small for Gestational Age

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
141 people
Ages
2 years to 11 years
Study type
Interventional

Who can take part

  • Your child must not have started puberty yet (boys under 11, girls under 10 at screening).
  • Your child was born with a birth weight or length that was below the 10th percentile for how many weeks they were in the womb.
  • Your child's height is well below average for their age and sex (more than 2 standard deviations below the mean).
  • Your child has not used growth hormones or other growth medicines for more than one month in the past.
  • Your child has a body mass index (BMI) between the 5th and 95th percentiles for their age and sex.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04798690Recruiting
Long-term growth injections for short children

This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.

Seoul, Seodaemun-gu
NCT01604395Recruiting
Long-term growth hormone check for children with short stature

This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.

Seoul
NCT07551804Recruiting· Phase 2
Growth hormone replacement therapy safety and effectiveness study

This study tests a new injectable growth hormone treatment for adults whose bodies don't produce enough growth hormone naturally. Researchers will measure how safe it is, how your body processes it, and whether it helps you feel better and function more normally.

Beijing
NCT06037473Recruiting
PEG growth hormone for short stature in children

This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.

Beijing, Beijing Municipality
NCT07260500Recruiting· Phase 2
Growth hormone study for short children born small for gestational age

This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.

Wuhan, Hubei
NCT06927310Recruiting· Phase 3
Growth Hormone Injection for Idiopathic Short Stature in Children

This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.

Hefei, Anhui

Hear when a new Small for Gestational Age trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.